{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:26:44Z","timestamp":1792099604272,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jiac.2021.06.003","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T08:09:20Z","timestamp":1623917360000},"page":"1447-1453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Usefulness of \u03b2-lactam and macrolide combination therapy for treating community-acquired pneumonia patients hospitalized in the intensive care unit: Propensity score analysis of a prospective cohort study"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7508-0442","authenticated-orcid":false,"given":"Akihiro","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Tokioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyoshi","family":"Washio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Irie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanao","family":"Otake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.jiac.2021.06.003_bib1","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.jiac.2021.06.003_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/cc4927","article-title":"Community-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC Case Mix Programme Database","volume":"10","author":"Woodhead","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.jiac.2021.06.003_bib3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.rmed.2013.04.003","article-title":"Mortality differences among hospitalized patients with community-acquired pneumonia in three world regions: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study","volume":"107","author":"Arnold","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.jiac.2021.06.003_bib4","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1186\/cc13812","article-title":"Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept Cohort","volume":"18","author":"Walden","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.jiac.2021.06.003_bib5","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock","volume":"45","author":"Rhodes","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jiac.2021.06.003_bib6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock","volume":"43","author":"Rhodes","year":"2016","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jiac.2021.06.003_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/thx.2009.121434","article-title":"BTS guidelines for the management of community acquired pneumonia in adults: update 2009","volume":"64","author":"Lim","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.jiac.2021.06.003_bib8","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/archinte.161.15.1837","article-title":"Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia","volume":"161","author":"Waterer","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jiac.2021.06.003_bib9","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1164\/rccm.200311-1578OC","article-title":"Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia","volume":"170","author":"Baddour","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2021.06.003_bib10","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/01.CCM.0000266755.75844.05","article-title":"Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock","volume":"35","author":"Rodr\u00edguez","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jiac.2021.06.003_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1183\/09031936.00054108","article-title":"Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia","volume":"33","author":"Restrepo","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2021.06.003_bib12","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00134-009-1730-y","article-title":"Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia","volume":"36","author":"Martin-Loeches","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jiac.2021.06.003_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jcrc.2017.08.048","article-title":"Impact of antibiotic therapy in severe community-acquired pneumonia: data from the Infauci Study","volume":"43","author":"Pereira","year":"2018","journal-title":"J Crit Care"},{"key":"10.1016\/j.jiac.2021.06.003_bib14","doi-asserted-by":"crossref","first-page":"R265","DOI":"10.1186\/cc13095","article-title":"Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: impact on survival and bacterial resistance","volume":"17","author":"Adrie","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.jiac.2021.06.003_bib15","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2021.06.003_bib16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"Lim","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.jiac.2021.06.003_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2021.06.003_bib18","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"Apache II: a severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jiac.2021.06.003_bib19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12890-017-0424-4","article-title":"Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort","volume":"17","author":"Ito","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jiac.2021.06.003_bib20","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/sim.5705","article-title":"The performance of different propensity score methods for estimating marginal hazard ratios","volume":"32","author":"Austin","year":"2013","journal-title":"Stat Med"},{"key":"10.1016\/j.jiac.2021.06.003_bib21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00134-008-1363-6","article-title":"Community-Acquired Pneumonia Intensive Care Units (CAPUCI) Study Investigators. Mortality in ICU patients with bacterial community-acquired pneumonia: when antibiotics are not enough","volume":"35","author":"Rodriguez","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jiac.2021.06.003_bib22","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1186\/cc13812","article-title":"ESICM\/ECCRN GenOSept Investigators. Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept Cohort","volume":"18","author":"Walden","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.jiac.2021.06.003_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12931-016-0397-5","article-title":"Risk factors for mortality in patients admitted to intensive care units with pneumonia","volume":"17","author":"Li","year":"2016","journal-title":"Respir Res"},{"key":"10.1016\/j.jiac.2021.06.003_bib24","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.medin.2015.07.005","article-title":"Evolution over a 15-year period of the clinical characteristics and outcomes of critically ill patients with severe community-acquired pneumonia","volume":"40","author":"Vall\u00e9s","year":"2016","journal-title":"Med Intensiva"},{"key":"10.1016\/j.jiac.2021.06.003_bib25","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/CCM.0b013e3182a66b9b","article-title":"Macrolides and mortality in critically ill patients with community-acquired pneumonia: a systematic review and meta-analysis","volume":"42","author":"Sligl","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jiac.2021.06.003_bib26","series-title":"The committee for the Japanese respiratory society in the management of pneumonia in adults guidelines 2017. The JRS guidelines for the management of pneumonia in adults 2017","year":"2017"},{"key":"10.1016\/j.jiac.2021.06.003_bib27","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1164\/rccm.200411-1444OC","article-title":"Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome","volume":"172","author":"Men\u00e9ndez","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2021.06.003_bib28","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1086\/498119","article-title":"Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America Guidelines on survival","volume":"41","author":"Bod\u00ed","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2021.06.003_bib29","doi-asserted-by":"crossref","first-page":"R8","DOI":"10.1186\/cc3934","article-title":"The impact of empiric antimicrobial therapy with a \u03b2-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia","volume":"10","author":"Mortensen","year":"2005","journal-title":"Crit Care"},{"key":"10.1016\/j.jiac.2021.06.003_bib30","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/jac\/dkr520","article-title":"Immunomodulatory effects of macrolides during community-acquired pneumonia: a literature review","volume":"67","author":"Kovaleva","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2021.06.003_bib31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.resinv.2015.05.003","article-title":"Update on the combination effect of macrolide antibiotics in community-acquired pneumonia","volume":"53","author":"O'Brien","year":"2015","journal-title":"Respir Investig"},{"key":"10.1016\/j.jiac.2021.06.003_bib32","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/jac\/dkm338","article-title":"Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro","volume":"60","author":"Anderson","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jiac.2021.06.003_bib33","first-page":"CD004418","article-title":"Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults","author":"Robenshtok","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jiac.2021.06.003_bib34","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/AAC.47.3.1151-1153.2003","article-title":"Lack of synergy of erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniae in vitro","volume":"47","author":"Lin","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2021.06.003_bib35","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1378\/chest.128.2.940","article-title":"The controversy of combination vs monotherapy in the treatment of hospitalized community-acquired pneumonia","volume":"128","author":"Weiss","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jiac.2021.06.003_bib36","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/14787210.2018.1512403","article-title":"Severe community-acquired pneumonia: current management and future therapeutic alternatives","volume":"16","author":"Garnacho-Montero","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jiac.2021.06.003_bib37","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1007\/s10096-015-2503-x","article-title":"Severe community-acquired pneumonia and positive urinary antigen test for S. pneumoniae: amoxicillin is associated with a favourable outcome","volume":"34","author":"Blanc","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2021.06.003_bib38","doi-asserted-by":"crossref","first-page":"106307","DOI":"10.1016\/j.rmed.2021.106307","article-title":"Pneumococcal community-acquired pneumonia in the intensive care unit: azithromycin remains protective despite macrolide resistance","volume":"177","author":"Shorr","year":"2021","journal-title":"Respir Med"},{"key":"10.1016\/j.jiac.2021.06.003_bib39","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"187","author":"Vestbo","year":"2013","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21001641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21001641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:03:00Z","timestamp":1761159780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X21001641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1341321X21001641"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2021.06.003","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-72358\/v1","asserted-by":"object"}]},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usefulness of \u03b2-lactam and macrolide combination therapy for treating community-acquired pneumonia patients hospitalized in the intensive care unit: Propensity score analysis of a prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2021.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}